Patient Site >>
GenPathHealthcare
Providers
  • Patient Login
  • Provider Login
  • Test Directory
  • Locations
  • Careers
  • Blog
  • Search
  • Menu Menu
  • Contact Us
  • Oncology
    • Overview
    • Pathology Testing
      • Brain Cancer Molecular Offerings
      • Gastroenterology Diagnostic Services
      • Sarcoma
      • STORMPATH
    • Hematopathology
    • OnkoSightTM Next Generation Sequencing
      • OnkoSightTM Technical Process
      • OnkoSight™ Exon Coverage
      • OnkoSightTM Features
    • Hereditary Cancer Testing
    • Resources
      • Meet Our Experts
      • Clinical Congresses
  • Urology
    • Overview
    • Testing Services
    • Prostate Health
      • 4kscore® Prostate Cancer Test
    • Bladder Cancer
    • Stone Analysis Risk
    • Sexually Transmitted Infections
    • Hereditary Cancer Testing
      • Prostate Cancer
      • Renal Cancer
    • Resources
      • Meet Our Experts
  • Women’s Health
    • Overview
    • Carrier Screening
      • Ashkenazi Jewish Cancer Screening
      • Cystic Fibrosis Carrier Screening
      • SMA Carrier Screening
      • Fragile X Screening
    • Sexual and Reproductive Health
      • Cervical Cancer And HPV Testing
    • Hereditary Cancer
    • Prenatal Screening
      • ClariTest
      • Maternal Serum Screening
      • Combined First Screen
      • Serum Integrated Screen
      • Integrated Screen
      • Sequential Screen
      • Quad Screen
      • Alpha-fetoprotein Screen
  • Oncology
  • Urology
    • Overview
    • Prostate Health
      • Prostate Cancer
    • Bladder Health
      • Bladder Cancer
    • Kidney Health
    • Sexually Transmitted Infections
  • Women’s Health
    • Overview
    • Preconception and Prenatal Genetic Testing
      • ClariTest® Core
      • Maternal Serum Screening
    • Sexually Transmitted Infections
    • Cervical Cancer
    • Hereditary Cancer
    • Resources for Patients
  • Healthcare Provider Site
  • Patients Site
  • Physician Tools
  • Locations
  • News
  • Contact Us
  • Patient Portal
  • Insurance
  • Insurance
  • Test Directory
  • Privacy Policy
You are here: Home1 / Healthcare Providers2 / Oncology3 / Resources4 / Clinical Congresses
  • ONCOLOGY
  • UROLOGY
  • WOMEN’S HEALTH
  • ABOUT GENPATH
  • Cost Estimator
  • Pathology Testing
    • Overview
    • Brain Cancer Molecular Offering
    • Gastroenterology Diagnostic Services
    • Sarcoma Test Offering
    • Stormpath®
  • Hematopathology
  • OnkoHRD™
  • OnkoSight Advanced™ Next Generation Sequencing
    • OnkoSight Advanced™ Complete
    • OnkoSight Advanced™ for Solid Tumors
      • OnkoSight Advanced™ for Lung Cancer
      • OnkoSight Advanced™ 523 Gene Reanalysis
    • OnkoSight Advanced™ for Hematologic Malignancies
      • OnkoSight Advanced™ for Myeloid Malignancies
      • OnkoSight Advanced™ Rapid AML Panel
      • OnkoSight Advanced™ for Chronic Lymphoid Neoplasms
      • OnkoSight Advanced™ for Plasma Cell Myeloma
      • OnkoSight Advanced™ Virtual Karyotyping in CLL and Plasma Cell Myeloma
    • OnkoSight Advanced™ Pan-Heme Fusion Panel
    • OnkoSight Advanced™ Features
    • OnkoSight Advanced™ Specimen Requirements
    • OnkoClone™ Minimal Residual Disease (MRD) Monitoring
  • OnkoRisk™ Hereditary Cancer Program
    • OnkoRisk™ Features
    • OnkoRisk™ Test Options
    • OnkoRisk™ Specimen Requirements
    • Genetic Counseling Support
    • OnkoRisk FAQ
  • Resources
    • Overview
    • Meet Our Experts
    • Clinical Congresses
    • Test Directory
    • Enhanced Services

Poster Presentations

AMP 2018

  • Clinical Targeted Next-Generation Sequencing Panel Testing in Non-Small Lung Cancer: Single Institution Experience at a High Scale National Reference Laboratory
  • Extended Myeloid Mutation Profiling using NGS in Triple-Negative Myeloproliferative Neoplasms: Single Institution Experience at a High Volume National Reference Laboratory

AMP 2017

  • Assessing the Possibility of RUNX1, ETV6 and GATA2 Related Germline Predisposition in Myeloid Neoplasms in a Somatic Cancer Setting

AMP 2015

  • Genomic Profiling can Provide Utility in Cases of Suspected Myeloid Neoplasia

NSGC 2016

  • Assessing the Possibility of RUNX1 Related Predisposition in Myeloid Neoplasms in a Somatic Cancer Setting

BioReference Health

About

Newsroom

Careers

Locations

Investors

Our Brands

BioReference Health®, LLC

The 4Kscore Test®

GenPath® Oncology

GenPath® Urology

GenPath® Women’s Health

PRIVACY

Annual Physician Notice

HIPAA Privacy Practices

HIPAA Incident

Website Privacy Policy

Accessibility and Language Services

Cookies

Cookie Settings

Patents

Connect

BioReference Health®


Join our newsletter

Read our blog to get the latest updates

481 Edward H. Ross Dr. Elmwood Park, NJ 07407-0621

GenPath Urology & Oncology (800) 627-1479

GenPath Women's Health (800) 633-4522

©2024 GenPath®, a division of BioReference Health®, LLC an OPKO Health Inc. Company
  • Twitter
Scroll to top